SBIR/STTR Research Award
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
Award amount
$2,000,000Program and phase
SBIR · Phase IIAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ID4PHARMA, LLC
- Proposal award date
- 2018-09-01
- Contract end date
- 2020-08-31
- UEI
- YP7FECLGFPU5
- Solicitation number
- PA16-302
- Topic code
- 102
Research abstract
TBD
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
Research funding history
2 SBIR/STTR records share this UEI (2017–2018). Reported award amounts total $2,300,000. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services